Ajay Parmar

[Ajay Parmar @AjayParmar_]

@Mike182035 @SeanDentBsc Hi Mike, not much more than what I've previously said which is that previous management never really clued heights in on many details. CC filled them in on ava6103.

[Ajay Parmar @AjayParmar_]

@SeanDentBsc I can also imagine it to be a hard sell to shareholders to say we've gone back to the people who screwed us over to get funding.

[Ajay Parmar @AjayParmar_]

@SeanDentBsc That I do not know but from what I also learned is that previous management did not fill them in on the full picture. AVA6103 and Chris did.

[Ajay Parmar @AjayParmar_]

@hughesy0707 Congratulations Richard!

[Ajay Parmar @AjayParmar_]

@MylesMcNulty Good to meet you again Myles! 👍🏽

[Ajay Parmar @AjayParmar_]

@ProudofusUK @Pluscachange201 Have a look into the Statute of Anne. It was the first law for copyrights starting in Britain. Many authors / song artists / software developers can have careers thanks to this 🇬🇧🤓. Rewards are merit driven and protected therefore it encourages innovation. It improved the globe!

[Ajay Parmar @AjayParmar_]

@asininitybeyond @SeanDentBsc @PJ_Crabb @Jenkoool @tom_the_bomb__ @avacta 3/3 Behaving like the company is for sale is a sure way to not get the best deal for long term shareholders. BP have to feel the pressure and making them face their patent cliffs should land us the best deal if we’ve not licensed out all assets. #AVCT

[Ajay Parmar @AjayParmar_]

@asininitybeyond @SeanDentBsc @PJ_Crabb @Jenkoool @tom_the_bomb__ @avacta 2/3 I think the board also have to consider for the scenario where AVA6103 does better than expected in the p1 trials and is expedited to p2 stage early. At that moment, would they wait for SGC money or go for another LD/ to the market again for more money? #AVCT

[Ajay Parmar @AjayParmar_]

@VisionaryProp

[Ajay Parmar @AjayParmar_]

@AM231982 @hughesy0707 6.1// @coughlin582 has been doing a great job improving the science, focusing the direction of the science and protecting it. It’s natural for investors to worry about their investments but the moats are in place to take advantage of. There’s also a good price to buy at. #AVCT

[Ajay Parmar @AjayParmar_]

@AM231982 @hughesy0707 5.4/ Hopefully, the perception of Avacta changes as we go along completing the trials and solving the financial concerns. Also, as these drugs aren’t OTC, brands shouldn’t play a huge decisive factor when selecting products to treat cancers. #AVCT